REGENXBIO, Inc. (RGNX)
6.125
+0.04
(+0.74%)
USD |
NASDAQ |
Jun 08, 16:00
6.125
0.00 (0.00%)
After-Hours: 18:36
REGENXBIO Market Cap : 316.15M for June 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ocugen, Inc. | 424.59M |
| Capricor Therapeutics, Inc. | 1.507B |
| Krystal Biotech, Inc. | 8.891B |
| Biogen, Inc. | 28.45B |
| AbbVie, Inc. | 394.03B |
Market Cap Related Metrics
| PS Ratio | 3.615 |
| PEG Ratio | -0.0140 |
| Price to Book Value | 15.00 |
| Price | 6.125 |
| Earnings Yield | -91.27% |
| PEGY Ratio | -0.0140 |